Mansi Shah, MD

Articles by Mansi Shah, MD

Why a Patient With Multiple Myeloma Might Decline Stem Cell Transplant: Mansi Shah, MD

ByHayden E. Klein,Laura Joszt, MA,Mansi Shah, MD

June 30th 2025

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, says Mansi Shah, MD.

How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD

ByHayden E. Klein,Laura Joszt, MA,Mansi Shah, MD

June 27th 2025

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple myeloma.

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

ByLaura Joszt, MA,Hayden E. Klein,Mansi Shah, MD

June 11th 2025

Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.

Mansi Shah, MD

Articles by Mansi Shah, MD

Why a Patient With Multiple Myeloma Might Decline Stem Cell Transplant: Mansi Shah, MD

How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

Latest Updated Articles

Trending on AJMC

Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC

New Biomarkers, Drug Targets Identified for Colorectal Cancer

Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability

Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations